Safety Follow-up Through 180 Days of Treatment with Remestemcel-L in Study MSB-GVHD001 in Pediatric Patients who have Failed to Respond to Steroid Treatment for Acute GVHD
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Mesoblast International Sarl
Start Date
October 19, 2015
End Date
October 18, 2018
Administered By
Institutes and Centers
Awarded By
Mesoblast International Sarl
Start Date
October 19, 2015
End Date
October 18, 2018